Brief: Aap Launches Human Clinical Study For Antibacterial Silver Coating Technology
10/12/2021 06:36
Dec 10 (Reuters) - AAP IMPLANTATE AG AAQ1k.DE :
* LAUNCHES WORLD'S FIRST HUMAN CLINICAL STUDY FOR
ANTIBACTERIAL
SILVER COATING TECHNOLOGY ON ANATOMICAL PLATES AND SCREWS FOR
FRACTURE TREATMENT
Source text for Eikon: ID:nEQ6STmzVa
Further company coverage: AAQ1k.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on aap Implantate AG
See all newsBrief: Aap Confirms Rubino Di Girolamo As CEO Through The End Of 2028 COO Agnieszka Mierzejewska Will Leave The Company At The End Of The Year
Brief: aap Implantate Says Postponement Of Publication Of Annual Financial Statements
Brief: Aap Implantate AG Says Increases Its EBITDA In 9M From - 1.6 Mln Euros To 0 Euros
Brief: aap Implantate Says Resumes Step-By-Step Restart Of It Systems
Brief: Aap Implantate Says Possible Cyber Attack On Co